PANACEABIO

Panacea Biotec Share PricePanacea Biotec

₹160.75
4.15 (2.65%)
As on 02 December, 2023 | 08:16 BSE: 531349 NSE: PANACEABIOISIN: INE922B01023

Panacea Biotec Performance

Day Range

  • Low 156.60
  • High 163.15
₹ 160.75

52 Week Range

  • Low 107.00
  • High 181.00
₹ 160.75
  • Open Price156.60
  • Previous Close156.60
  • Volume486916

Start SIP in Panacea Biotec

Start SIP

Panacea Biotec Share Price

  • Over 1 Month 7.2%
  • Over 3 Month 19.21%
  • Over 6 Month 37.16%
  • Over 1 Year 16.23%

Panacea Biotec Key Statistics

P/E Ratio 105
PEG Ratio -1.1
Market Cap Cr 985
Price to Book Ratio 1.2
EPS -15.2
Dividend 0
Relative Strength Index 55.34
Money Flow Index 60.26
MACD Signal -0.11
Average True Range 6.18

Panacea Biotec Investment Rating

  • Master Rating:
  • Panacea Biotec (Nse) has an operating revenue of Rs. 516.34 Cr. on a trailing 12-month basis. An annual revenue de-growth of -24% needs improvement, Pre-tax margin of 3% needs improvement, ROE of -4% is poor and needs improvement. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 17% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 26 which is a POOR score indicating inconsistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 64 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Panacea Biotec Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 95897572496142
Operating Expenses Qtr Cr 858372605513361
Operating Profit Qtr Cr 107312-6-72-19
Depreciation Qtr Cr 5566667
Interest Qtr Cr 4333221
Tax Qtr Cr 00250000
Net Profit Qtr Cr 31-2013-7-74-25
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 292248
Operating Expenses Annual Cr 320308
Operating Profit Annual in Cr -63-73
Depreciation Cr 2526
Interest Annual Cr 107
Tax Annual Cr 250
Net Profit Annual Cr -88-94
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr -53
Cash from Investing Activity Annual Cr 40
Cash from Financing Annual Activity Cr 10
Net Cash Flow Annual Cr -3
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 326398
Fixed Assets Annual Cr 463455
Total Non Current Assets Annual Cr 519473
Total Current Assets Annual Cr 205289
Total Assets Annual Cr 724762
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 5364
ROE Annual % -27-24
ROCE Annual % -11-17
Total Debt to Total Equity Annual --
EBDIT Annual Margin % -11-26
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 143129129115105111141
Operating Expenses Qtr Cr 147140135124109191171
Operating Profit Qtr Cr -4-10-6-9-4-80-30
Depreciation Qtr Cr 9910-17101011
Interest Qtr Cr 111271131
Tax Qtr Cr 1231385371
Net Profit Qtr Cr -811-131916-561,237
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 512672
Operating Expenses Annual Cr 558675
Operating Profit Annual in Cr -98-14
Depreciation Cr 3944
Interest Annual Cr 4181
Tax Annual Cr 47371
Net Profit Annual Cr -341,078
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr -108
Cash from Investing Activity Annual Cr 1,283
Cash from Financing Annual Activity Cr -1,176
Net Cash Flow Annual Cr -2
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 844853
Fixed Assets Annual Cr 642607
Total Non Current Assets Annual Cr 703742
Total Current Assets Annual Cr 5681,041
Total Assets Annual Cr 1,2711,783
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 137138
ROE Annual % -4127
ROCE Annual % -9-5
Total Debt to Total Equity Annual --
EBDIT Annual Margin % -100

Panacea Biotec Technicals

EMA & SMA

Current Price
₹160.75
4.15 (2.65%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹157.02
  • 50 Day
  • ₹154.85
  • 100 Day
  • ₹148.53
  • 200 Day
  • ₹143.03
  • 20 Day
  • ₹156.72
  • 50 Day
  • ₹159.71
  • 100 Day
  • ₹146.31
  • 200 Day
  • ₹133.75

Panacea Biotec Resistance and Support

PIVOT
₹160.17
Resistance
First Resistance 163.73
Second Resistance 166.72
Third Resistance 170.28
RSI 55.34
MFI 60.26
MACD Single Line -0.11
MACD 0.50
Support
First Resistance 157.18
Second Resistance 153.62
Third Resistance 150.63

Panacea Biotec Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 509,720 31,087,823 60.99
Week 226,035 13,214,021 58.46
1 Month 171,348 8,802,149 51.37
6 Month 698,831 20,419,840 29.22

Panacea Biotec Result Highlights

Panacea Biotec Synopsis

NSE-Medical-Generic Drugs

Panacea Biotec L is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 257.07 Cr. and Equity Capital is Rs. 6.13 Cr. for the Year ended 31/03/2023. Panacea Biotec Ltd. is a Public Limited Listed company incorporated on 02/02/1984 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L33117PB1984PLC022350 and registration number is 022350.
Market Cap 985
Sales 331
Shares in Float 1.59
No of funds 6
Yield
Book Value 3.03
U/D Vol ratio 1.2
LTDebt / Equity 31
Alpha 0.06
Beta 0.77

Panacea Biotec

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 73.59%73.59%73.59%73.59%
Mutual Funds
Foreign Portfolio Investors 0.26%0.22%0.18%0.18%
Individual Investors 19.2%16.15%15.82%15.97%
Others 6.95%10.04%10.41%10.26%

Panacea Biotec Management

Name Designation
Mr. Soshil Kumar Jain Chairman
Dr. Rajesh Jain Managing Director
Mr. Sandeep Jain Joint Managing Director
Mr. Ankesh Jain Whole Time Director
Mr. R L Narasimhan Non Executive Director
Mr. N N Khamitkar Non Executive Director
Mr. K M Lal Non Executive Director
Mrs. Manjula Upadhyay Non Executive Director
Mr. Bhupinder Singh Non Executive Director
Mr. Mukul Gupta Non Executive Director
Mr. Narotam Kumar Juneja Non Executive Director

Panacea Biotec Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Panacea Biotec Corporate Action

Date Purpose Remarks
2023-11-10 Quarterly Results
2023-08-12 Quarterly Results
2023-05-30 Audited Results
2023-02-14 Quarterly Results
2022-11-14 Quarterly Results

Panacea Biotec MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 8

Panacea Biotec FAQs

What is Share Price of Panacea Biotec ?

Panacea Biotec share price is ₹160 As on 02 December, 2023 | 08:02

What is the Market Cap of Panacea Biotec ?

The Market Cap of Panacea Biotec is ₹984.6 Cr As on 02 December, 2023 | 08:02

What is the P/E ratio of Panacea Biotec ?

The P/E ratio of Panacea Biotec is 105 As on 02 December, 2023 | 08:02

What is the PB ratio of Panacea Biotec ?

The PB ratio of Panacea Biotec is 1.2 As on 02 December, 2023 | 08:02

Q2FY23